Global Acrolein (CAS 107-02-8) Market Outlook 2018-2023

February 2019 | 119 pages | ID: G8168DFE17CEN
Gen Consulting Company

Abstracts

The 'Global Acrolein (CAS 107-02-8) Market Outlook 2018-2023' offers detailed coverage of acrolein industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading acrolein producers to provide exhaustive coverage of the market for acrolein. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.

The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global acrolein market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.

Key Regions

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Key Vendors

• Bluestar Adisseo Company
• Evonik Industries AG
• Hubei Jinghong Chemical Co., Ltd.
• Hubei Shengling Technology Co., Ltd.
• Shandong Xinglu Biological Technology Co., Ltd.
• Wuhan Ruiji Chemical Co., Ltd.
• Wuhan Youji Industries Co., Ltd.
• Zibo Xinglu Chemical Industry Co., Ltd.
• request free sample to get a complete list of companies

Key Questions Answered in This Report

• Analysis of the acrolein market including revenues, future growth, market outlook
• Historical data and forecast
• Regional analysis including growth estimates
• Analyzes the end user markets including growth estimates.
• Profiles on acrolein vendors including products, sales/revenues, SWOT, and market position, recent developments.
• Market structure, market drivers and restraints.

Contents

PART 1. SUMMARY

PART 2. REPORT METHODOLOGY

2.1 Methodology
2.2 Data Source

PART 3. INTRODUCTION

PART 4. INDUSTRY VALUE CHAIN

4.1 Acrolein Industry Value Chain Analysis
4.2 Upstream
4.3 End-uses
4.4 Distributors

PART 5. COMPETITIVE LANDSCAPE

5.1 Global Acrolein Sales & Share by Company (2013-2018)
5.2 Global Acrolein Revenue & Share by Company (2013-2018)
5.3 Pricing Trends
5.4 Competitive Trends

PART 6. SEGMENTATION BY TYPE

6.1 Global Acrolein Sales Volume by Type (2013-2018)
6.2 Global Acrolein Revenue by Type (2013-2018)
6.3 Global Acrolein Price by Type (2013-2018)

PART 7. SEGMENTATION BY APPLICATION

7.1 Global Acrolein Sales Volume by Application (2013-2018)
7.2 Global Acrolein Revenue by Application (2013-2018)
7.3 Global Acrolein Price by Application (2013-2018)

PART 8. REGIONAL PERSPECTIVES

8.1 Overview
8.2 North America
  8.2.1 Market Size (Volume & Value)
  8.2.2 by Application
  8.2.3 by Country (U.S., Canada, Mexico, etc.)
8.3 Europe
  8.3.1 Market Size (Volume & Value)
  8.3.2 by Application
  8.3.3 by Country (Germany, UK, France, Spain, Italy, etc.)
8.4 Asia-Pacific
  8.4.1 Market Size (Volume & Value)
  8.4.2 by Application
  8.4.3 by Country (China, Japan, Korea, India, etc.)
8.5 Middle East & Africa
  8.5.1 Market Size (Volume & Value)
  8.5.2 by Application
  8.5.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)
8.6 South America
  8.6.1 Market Size (Volume & Value)
  8.6.2 by Application
  8.6.3 by Country (Brazil, Argentina, Colombia, etc.)

PART 9. COMPANY PROFILES

9.1 Company Profile
9.2 Product Offered
9.3 Business Performance
9.4 Recent Developments

PART 10. MARKET FORECAST

10.1 Global Acrolein Market Size Forecast (2018-2023)
  10.1.1 Global Acrolein Sales Forecast (2018-2023)
  10.1.2 Global Acrolein Revenue Forecast (2018-2023)
10.2 Forecast by Region
  10.2.1 North America
  10.2.2 Europe
  10.2.3 Asia-Pacific
  10.2.4 Middle East & Africa
  10.2.5 South America
10.3 Forecast by Type
10.4 Forecast by Application

PART 11. MARKET DRIVERS

11.1 Opportunities
11.2 Challenges
11.3 Economic/Political Environmental

PART 12. INDUSTRY ACTIVITY

12.1 M&As, JVs and Partnership
12.2 Other Developments

PART 13. APPENDIX

DISCLAIMER
ABOUT GEN CONSULTING COMPANY